Keyphrases
Inflammatory Bowel Disease
100%
Host-microbe Interactions
66%
Clinical Phenotype
66%
Transcriptional Network
38%
Microbiota
36%
Biological Therapy
33%
Gut Microbiome
33%
Gut Metabolome
33%
Predictive Value
33%
Microbial Composition
27%
TNF-α Antagonists
27%
Mucosa-associated Microbiota
27%
Microbiome
25%
Fatty Acid Metabolism
19%
Fibrostenotic
19%
16S Ribosomal RNA (16S rRNA)
19%
Metallothionein
19%
High-level Expression
19%
Stenotic Lesion
19%
Intestinal Microbiota
19%
Gene Expression
19%
Transcriptomics
19%
Bifidobacterium
19%
Bacteria Interaction
19%
Immunity Genes
19%
Intestinal Biopsy
19%
Ruminococcaceae
19%
Specific Interactions
19%
Precision Medicine
19%
Inflammation-related Pathways
19%
RNA Sequencing (RNA-seq)
19%
Fatty Acid Metabolism Genes
19%
Bacteroides
19%
Fibrostenosis
16%
Mucosal Gene Expression
16%
Treatment Response
16%
Fecal Metabolites
16%
Intestinal Cells
11%
Crohn's Disease
11%
Bowel Control
11%
Dysregulation
11%
Cell Enrichment
9%
Intestinal Epithelial Cells
8%
Targeted Therapeutics
8%
Inflammatory Genes
8%
Disease Course
8%
Macrophage Cells
8%
Tissue Inflammation
8%
Tissue Location
8%
Individual Specificity
8%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Microflora
55%
Gut Microbiome
33%
Metabolome
33%
Microbiome
25%
Fatty Acid Metabolism
22%
Metallothionein
15%
Gene Expression
14%
Bifidobacterium
14%
Crohn's Disease
14%
Tumor Necrosis Factor
11%
RNA Sequencing
11%
Bacteroides
11%
Intestine Flora
11%
Ruminococcaceae
11%
Metabolite
8%
Metagenomics
8%
Vedolizumab
8%
Biological Product
8%
Sample Size
8%
Ustekinumab
8%
Taxon
7%
Mucosa
7%
